Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life Clinical Trials Arena
Year: 2025
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal – The Wall Street Journal
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal The Wall Street Journal
Ono earmarks $940m to gain rare blood cancer therapy from Ionis
Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat…
Roche broadens obesity drug plans with $1.65B Zealand deal – BioPharma Dive
Roche broadens obesity drug plans with $1.65B Zealand deal BioPharma Dive
Ending of US weight-loss drug shortages prompts compounder complaints – Chemistry World
Ending of US weight-loss drug shortages prompts compounder complaints Chemistry World
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery – HealthDay
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery HealthDay
Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications – Medical Xpress
Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications Medical Xpress
Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures
The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain portfolio.
Ozempic users say their exes are attempting to reconnect with them after weight loss: ‘Second chance at love’ – New York Post
Ozempic users say their exes are attempting to reconnect with them after weight loss: ‘Second chance…
Vori Health secures $53m funding to support musculoskeletal care
Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care…